United Therapeutics

YTD

ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,400

Employees1,400

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,400

Employees1,400

UTHR Key Statistics

Market cap

23.87B

Market cap23.87B

Price-Earnings ratio

19.43

Price-Earnings ratio19.43

Dividend yield

—

Dividend yield—

Average volume

820.59K

Average volume820.59K

High today

$557.77

High today$557.77

Low today

$547.14

Low today$547.14

Open price

$547.14

Open price$547.14

Volume

17.55K

Volume17.55K

52 Week high

$609.35

52 Week high$609.35

52 Week low

$409.07

52 Week low$409.07

Stock Snapshot

With a market cap of 23.87B, United Therapeutics(UTHR) trades at $556.58. The stock has a price-to-earnings ratio of 19.43.

On 2026-10-20, United Therapeutics(UTHR) stock moved within a range of $547.14 to $557.77. With shares now at $556.58, the stock is trading +1.7% above its intraday low and -0.2% below the session's peak.

Trading activity shows a volume of 17.55K, compared to an average daily volume of 820.59K.

The stock's 52-week range extends from a low of $409.07 to a high of $609.35.

UTHR News

Investing.com 2h

United Therapeutics opens third xenograft production facility - Investing.com

...

TipRanks 1d

United Therapeutics announces FDA clearance to proceed with SUMMIT trial

United Therapeutics (UTHR) announced that the U.S. Food and Drug Administration has granted clearance under the company’s investigational new drug application t...

TipRanks 6d

United Therapeutics Reaches Major Pulmonary Hypertension Settlement

United Therapeutics ( (UTHR) ) has issued an announcement. On October 13, 2026, United Therapeutics entered a settlement agreement with Liquidia Technologies t...

Analyst ratings

82%

of 17 ratings

Buy

82.4%

Hold

11.8%

Sell

5.9%

More UTHR News

TipRanks 6d

Liquidia Stock Pops as $380.7M Deal Ends Legal Battle with United Therapeutics

Liquidia (LQDA) stock jumped about 47% in Wednesday’s pre-market trading after the biopharmaceutical company focused on respiratory and vascular diseases announ...

Benzinga 6d

Liquidia Corporation Stock Is Trending In After-Hours Following United Therapeutics Settlement: What You Should Know

Liquidia Corporation (NASDAQ:LQDA) shares jumped 42.48% to $38.20 after the bell on Tuesday after the company announced a global settlement with Maryland-based...

TipRanks 7d

Liquidia to pay $175M UTHR after settlement agreement

Liquidia (LQDA) and United Therapeutics (UTHR) reached a global settlement agreement that resolves all pending litigation between the companies. YUTREPIA, or tr...

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Sterling Infrastructure

Argan

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.